Paper
0
Update on GMALL Trial 08/2013 Shows Durable Favorable Outcome of Newly Diagnosed Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) with Imatinib, Dose-Reduced Induction Followed By Stem Cell Transplantation
Authors
Roman Pfeifer,Fabian Lang
Walter Fiedler,Matthias Stelljes,Folker Schneller,Björn Steffen,Boris Böll,Andreas Viardot,Christoph Faul,Lino Teichmann,Hendrik Poeck,Joerg Westermann,Kerstin Schäfer‐Eckart,Thomas Heinicke,Thomas Burmeister,Stefan Schwartz,Monika Brueggemann,Hubert Serve
+16 authors
,Nicola GoekbugetJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.